CLYM
Climb Bio Inc
11.90$
-5.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.7% | 99.8% | 99.9% | 100.0% | 88.9% | 71.3% | 50.0% | 45.4% | 49.9% | 63.1% | 74.4% | 75.8% | |
| 50.9% | 84.3% | 96.1% | 98.7% | 65.8% | 40.2% | 14.5% | 11.8% | 14.2% | 21.3% | 5.5% | 17.9% | |
| 95.3% | 96.7% | 96.1% | 98.7% | 87.0% | 69.5% | 48.9% | 44.0% | 47.7% | 60.3% | 71.9% | 74.4% | |
| 1.7% | 2.2% | 1.8% | – | 0.4% | 0.5% | 0.7% | – | – | – | – | – | |
| 2.7% | 2.6% | 2.7% | 1.7% | 1.5% | 2.4% | 3.7% | 3.4% | 2.9% | 4.3% | 2.8% | 2.7% | |
| 2.6% | 2.6% | 2.7% | 1.7% | 1.5% | 2.3% | 3.5% | 3.2% | 2.7% | 4.2% | 2.7% | 2.4% | |
| 0.4% | 0.3% | 0.2% | 0.0% | 0.0% | 0.1% | 0.1% | 0.1% | 0.1% | 0.2% | 0.2% | 0.2% | |
| 0.7% | 0.1% | 0.1% | 0.2% | 0.1% | 0.3% | 0.4% | 0.5% | 0.3% | 1.4% | 0.6% | 0.5% | |
| 97.3% | 97.4% | 97.3% | 98.3% | 98.5% | 97.6% | 96.3% | 96.6% | 97.1% | 95.7% | 97.2% | 97.3% | |
| -135.1% | -141.2% | -144.2% | -94.0% | -99.7% | -105.8% | -124.9% | -134.8% | -149.3% | -172.7% | -199.2% | -128.7% | |
| 24.0% | 24.7% | 25.3% | 13.4% | 30.2% | 29.8% | 33.6% | 35.1% | 37.3% | 40.2% | 44.8% | 30.9% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.